Concerns Regarding Follow-Up Duration and End Point Validity
To the Editor Nikitas et al1 demonstrated favorable tolerability of stereotactic body radiotherapy (SBRT) to the prostate bed following radical prostatectomy. Notably, no measurable differences in urinary, bowel, or sexual function were observed over a 2-year period.
Authors
- Masahiro Kami (ORCID: https://orcid.org/0000-0002-5130-3832)
- Michioki Endo
Institutions
- Hyogo Prefectural Awaji Medical Center (JP)
- Medical Governance Research Institute (JP)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1001/jamaoncol.2025.3780
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00